Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Aberrant DOCK2, GRASP, HIF3A and PKFP Hypermethylation has Potential as a Prognostic Biomarker for Prostate Cancer
Authors
Keywords
-
Journal
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
Volume 20, Issue 5, Pages 1173
Publisher
MDPI AG
Online
2019-03-08
DOI
10.3390/ijms20051173
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The clinical significance and biological function of tropomyosin 4 in colon cancer
- (2018) Rui Yang et al. BIOMEDICINE & PHARMACOTHERAPY
- Dock2 in the development of inflammation and cancer
- (2018) Yayun Chen et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Outcomes and Prognostic Factors in Men Receiving Androgen Deprivation Therapy for Prostate Cancer Recurrence after Radical Prostatectomy
- (2018) Praful Ravi et al. JOURNAL OF UROLOGY
- EAU-ESTRO-SIOG Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent
- (2017) Nicolas Mottet et al. EUROPEAN UROLOGY
- A pathology atlas of the human cancer transcriptome
- (2017) Mathias Uhlen et al. SCIENCE
- Stabilization of phosphofructokinase 1 platelet isoform by AKT promotes tumorigenesis
- (2017) Jong-Ho Lee et al. Nature Communications
- Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden
- (2017) Zachary R. Chalmers et al. Genome Medicine
- Cell-free DNA Comprises an In Vivo Nucleosome Footprint that Informs Its Tissues-Of-Origin
- (2016) Matthew W. Snyder et al. CELL
- Genome-wide DNA methylation analysis in hepatocellular carcinoma
- (2016) NOBUHISA YAMADA et al. ONCOLOGY REPORTS
- Screening of Differently Expressed miRNA and mRNA in Prostate Cancer by Integrated Analysis of Transcription Data
- (2016) Yanan Sun et al. UROLOGY
- RHCG and TCAF1 promoter hypermethylation predicts biochemical recurrence in prostate cancer patients treated by radical prostatectomy
- (2016) Siri H. Strand et al. Oncotarget
- Observational studies and the natural history of screen-detected prostate cancer
- (2015) Peter C. Albertsen CURRENT OPINION IN UROLOGY
- Lower Levels of Human MOB3B Are Associated with Prostate Cancer Susceptibility and Aggressive Clinicopathological Characteristics
- (2015) Eun-Ah Kim et al. JOURNAL OF KOREAN MEDICAL SCIENCE
- Tissue-based map of the human proteome
- (2015) M. Uhlen et al. SCIENCE
- What is the optimal definition of misclassification in patients with very low-risk prostate cancer eligible for active surveillance? Results from a multi-institutional series
- (2015) Giorgio Gandaglia et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- DNA methylation ofPITX2predicts poor survival in men with prostate cancer
- (2014) Nataša Vasiljević et al. Biomarkers in Medicine
- A panel of genes methylated with high frequency in colorectal cancer
- (2014) Susan M Mitchell et al. BMC CANCER
- Hypermethylation of the GABRE miR-452 miR-224 Promoter in Prostate Cancer Predicts Biochemical Recurrence after Radical Prostatectomy
- (2014) H. Kristensen et al. CLINICAL CANCER RESEARCH
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012
- (2014) Jacques Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Prognostic DNA Methylation Markers for Prostate Cancer
- (2014) Siri Strand et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Active surveillance for clinically localized prostate cancer--A systematic review
- (2014) Frederik B. Thomsen et al. JOURNAL OF SURGICAL ONCOLOGY
- Marmal-aid – a database for Infinium HumanMethylation450
- (2013) Robert Lowe et al. BMC BIOINFORMATICS
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012
- (2013) J. Ferlay et al. EUROPEAN JOURNAL OF CANCER
- DNA Methylation Signatures for Prediction of Biochemical Recurrence After Radical Prostatectomy of Clinically Localized Prostate Cancer
- (2013) Christa Haldrup et al. JOURNAL OF CLINICAL ONCOLOGY
- Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer
- (2013) Hsin-Yao Tang et al. Journal of Proteomics
- Global Methylation Profiling for Risk Prediction of Prostate Cancer
- (2012) S. Mahapatra et al. CLINICAL CANCER RESEARCH
- Early Salvage Radiation Therapy Does Not Compromise Cancer Control in Patients with pT3N0 Prostate Cancer After Radical Prostatectomy: Results of a Match-controlled Multi-institutional Analysis
- (2012) Alberto Briganti et al. EUROPEAN UROLOGY
- Peroxiredoxins and tropomyosins as plasma biomarkers for lung cancer and asbestos exposure
- (2012) Annina Rostila et al. LUNG CANCER
- The CAPRA-S score
- (2011) Matthew R. Cooperberg et al. CANCER
- CXCL13 mediates prostate cancer cell proliferation through JNK signalling and invasion through ERK activation
- (2011) C. P. El-Haibi et al. CELL PROLIFERATION
- A novel hairless mouse model for malignant melanoma
- (2011) Nguyen Dinh Thang et al. JOURNAL OF DERMATOLOGICAL SCIENCE
- Time Trends and Local Variation in Primary Treatment of Localized Prostate Cancer
- (2010) Matthew R. Cooperberg et al. JOURNAL OF CLINICAL ONCOLOGY
- DNA methylation changes in prostate cancer: current developments and future clinical implementation
- (2009) Mohammad Obaidul Hoque EXPERT REVIEW OF MOLECULAR DIAGNOSTICS
- Differences in gene expression levels between early and later stages of human lung development are opposite to those between normal lung tissue and non-small lung cell carcinoma
- (2008) Eugene P. Kopantzev et al. LUNG CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now